SiriusPoint (SPNT) Q4 2025 earnings summary

Executive summary

• Achieved strong financial performance in Q4 and FY25, with net income up 141% to $444 million and book value per diluted share rising 28%.

• Disciplined underwriting led to a core combined ratio of 91.7% for the year and 92.9% for Q4, marking thirteen consecutive quarters of underwriting profit.

• Significant portfolio reshaping through the sale of Armada and Arcadian MGAs, generating $390 million in liquidity and recognized gains.

• Announced $100 million share buyback and redemption of $200 million Series B Preference Shares, reducing leverage to historic lows.

• Attracted 18 senior leaders and promoted six internally, supporting ongoing performance momentum.

Financial highlights

• Gross written premium grew 16% year-over-year to $3.7 billion for FY25; Q4 GWP up 18% to $897 million.

• Net income for 2025 increased 141% to $444 million; operating income reached $310 million with EPS up 49% to $2.55.

• Book value per diluted common share (ex. AOCI) rose 24% to $18.10; common shareholders' equity increased to $2.3 billion.

• Investment income for FY25 was $275 million, with 81% of the portfolio in investment-grade fixed income.

• Tangible book value per diluted common share at year-end: $17.62.

Outlook and guidance

• Operating ROE reached 16.2% for FY25, exceeding the 12%-15% target for the third consecutive year.

• Insurance segment combined ratio expected to remain around 91.7%–91.8% in 2026, with potential ±0.5 point variation.

• Fee income for 2026 projected at ~$30 million, with bolt-on acquisitions expected to add materially in 2027.

• $100 million share buyback planned over 12 months, expected to be accretive to EPS and ROE.

• Management confident in navigating 2026 market conditions and continuing to outperform ROE targets.